| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8457845 | Nuclear Medicine and Biology | 2013 | 10 Pages |
Abstract
The present study demonstrates that 18F-labeled BBN analogue [18F]BBN-2 is a suitable PET radiotracer with favorable metabolic stability in vivo for molecular imaging of GRP receptor-positive prostate cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Susan Richter, Melinda Wuest, Stephanie S. Krieger, Buck E. Rogers, Matthias Friebe, Ralf Bergmann, Frank Wuest,